Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07820670) titled 'Rivaroxaban vs Enoxaparin After Cesarean Section: Laboratory Thromboprophylaxis Outcomes' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Wolfson Medical Center
Condition:
Postpartum Period
Cesarean Section Surgery
VTE (Venous Thromboembolism)
Intervention:
Drug: Rivaroxaban
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: December 1, 2025
Target Sample Size: 62
Countries of Recruitment:
Israel
To know more, visit https://clinicaltrials.gov...